In recognition of their increased vulnerability to the virus, the Centers for Disease Control and Prevention (CDC) have authorized an extra dose of the COVID-19 vaccination for people 65 years of age and older.
CDC Director Mandy Cohen emphasized the importance of this decision, highlighting the disproportionate impact of COVID-19 on older adults. Cohen stated, “Today’s recommendation allows older adults to receive an additional dose of this season’s COVID-19 vaccine to provide added protection.”
Addressing Vulnerability
This decision follows a recent vote by CDC advisors advocating for an extra COVID-19 vaccine dose for older Americans this spring.
The recommended shot constitutes a booster of the initial vaccine administered in September, targeting the XBB.1.5 strain, although no longer prevalent in the US Nevertheless, experts assert that this updated vaccine remains effective against the current dominant strain, JN.1.
While a substantial portion of the population has acquired immunity through vaccination or previous infection, concerns persist regarding waning immunity, particularly among older demographics.
Read more: Deep-Sea Exploration Near Chile Discovers Over 100 New Species
Boosting Protection for Older Americans Against COVID-19
The CDC’s external vaccine experts reviewed data illustrating the current status of COVID-19 in the US, noting that coronavirus hospitalization rates are highest among older Americans, with the highest COVID-19 death rates observed among individuals aged 75 and older.
Despite the absence of clinical trial data for the additional updated COVID-19 shot, the CDC cited past evidence demonstrating the efficacy of supplementary doses in older adults.
Survey data indicates a higher willingness among older Americans to receive the initial updated shots compared to younger populations. Approximately 42% of adults aged 65 and above have already received the shot, in contrast to 22% of all adults.
Given that it has been approximately five months since the initial updated vaccine rollout, older populations appear prepared to undergo the vaccination process again. Survey findings presented during the CDC meeting revealed a strong inclination among those aged 65 and above to receive a second shot, with 68% expressing definite willingness
Read more: New Blood Test Offers Hope For Schizophrenia Diagnosis And Treatment
